We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · February 06, 2019

Locoregional Treatment Improves Overall Survival in De Novo Metastatic Breast Cancer

Annals of Surgical Oncology


Additional Info

Disclosure statements are available on the authors' profiles:

Annals of Surgical Oncology
Survival Impact of Locoregional Treatment of the Primary Tumor in De Novo Metastatic Breast Cancers in a Large Multicentric Cohort Study: A Propensity Score-Matched Analysis
Ann. Surg. Oncol 2019 Feb 01;26(2)356-365, E Pons-Tostivint, Y Kirova, A Lusque, M Campone, J Geffrelot, C Mazouni, A Mailliez, D Pasquier, N Madranges, N Firmin, A Crouzet, A Gonçalves, C Jankowski, T De La Motte Rouge, N Pouget, B de La Lande, D Mouttet-Boizat, JM Ferrero, L Uwer, JC Eymard, MA Mouret-Reynier, T Petit, M Robain, T Filleron, C Cailliot, F Dalenc

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading